Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| SEM6B | Q9H3T3 | Semaphorin-6B (Semaphorin-Z) (Sema Z) | Disease related genesHuman disease related genesPlasma proteins | 1 | Epilepsy | Receptor-signaling mediation | 1 | 0.40 | ||
| SHAN2 | Q9UPX8 | SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1) | Disease related genesHuman disease related genesPlasma proteins | AutismAutism spectrum disorder | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.40 | |||
| SL9A3 | P48764 | Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3) | Disease related genesFDA approved drug targetsHuman disease related genes | 13 | Angina pectorisBreathing abnormalityCardiac arrhythmia | Clinical-translation mediationFusion and delivery mediation | 1 | 0.40 | ||
| SL9A9 | Q8IVB4 | Sodium/hydrogen exchanger 9 (Na(+)/H(+) exchanger 9) (NHE-9) (Solute carrier family 9 member 9) | Disease related genesHuman disease related genesMetabolic proteins | 13 | AutismAutism spectrum disorder | Clinical-translation mediationFusion and delivery mediation | 1 | 0.40 | ||
| XRP2 | O75695 | Protein XRP2 | Disease related genesHuman disease related genesPredicted intracellular proteins | Retinitis pigmentosa | Other mediation | 1 | 0.40 | |||
| TN13B | Q9Y275 | Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator) (BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1) (TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form] | Cancer-related genesCD markersFDA approved drug targets | 1 | Lupus erythematosusLymphomaMultiple myeloma | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 8 | 0.38 | ||
| LRC8C | Q8TDW0 | Volume-regulated anion channel subunit LRRC8C (Factor for adipocyte differentiation 158) (Leucine-rich repeat-containing protein 8C) | Predicted membrane proteinsTransporters | 4 | DwarfismIntellectual disability | Fusion and delivery mediation | 6 | 0.38 | ||
| TRPM4 | Q8TD43 | Transient receptor potential cation channel subfamily M member 4 (hTRPM4) (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (Melastatin-4) | Disease related genesHuman disease related genesPotential drug targets | 6 | Palmoplantar keratoderma | Fusion and delivery mediationImmune mediationMetabolism mediation | 6 | 0.38 | ||
| TUB | P50607 | Tubby protein homolog | Disease related genesPredicted intracellular proteins | ObesityBladder cancerBrain cancer | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 6 | 0.38 | |||
| AT1A2 | P50993 | Sodium/potassium-transporting ATPase subunit alpha-2 (Na(+)/K(+) ATPase alpha-2 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-2) | Disease related genesEnzymesHuman disease related genes | 10 | EpilepsyIntellectual disability | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 0 | 0.35 |